Journal article
A303 SAFETY AND EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH LIVER CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Abstract
AbstractBackground
Direct oral anticoagulants (DOACs) are widely used for treatment of venous thromboembolism (VTE) and stroke prophylaxis in patients with atrial fibrillation. Liver cirrhosis increases the risk of conditions necessitating anticoagulation, but also increases bleeding risks, complicating anticoagulation use. DOACs may be suitable for chirrotic patients as their reliance on hepatic elimination is reduced compared to traditionally …
Authors
Tham D; Yu W; Zhao L; Kou R; Kherani J; Li P; Sreeraman S; Eshaghpour A; Li A; Crowther M
Journal
Journal of the Canadian Association of Gastroenterology, Vol. 7, No. Supplement_1, pp. 246–247
Publisher
Oxford University Press (OUP)
Publication Date
February 14, 2024
DOI
10.1093/jcag/gwad061.303
ISSN
2515-2084